XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.99

-1.5%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (13688)	5/28/2000 6:02:00 PM
From: Bluegreen	Read Replies (2) of 17367

Cacaito, break out the Peptobismol while I tell my opinions on Baxter. They and several other Pharms looked at Neuprex. Makes no sense for Baxter to pluck down ten million IF they didn't think it works. Irregardless of trial situation it either works or it doesn't. Baxter figures it works and that they will find a way to get it approved. You stating that all they wanted for their 10 million was to see if it got Meningo. through doesn't make sense!!!!! If it got approved and didn't work WHAT GOOD IS THAT FOR 10 MILLION!!!! Would that be smart of Baxter? Get a drug approved that doesn't work??? Why would Baxter touch a drug that didn't work??? I can only hope that Xoma goes below 3 or 2 a share. And guess what? In my opinion I am not the only one who thinks that way. In the meantime it is up to Baxter to ram through Neuprex in ANY way it can. Why? Wouldn't it be a miracle if it DIDN'T work??? ONE MORE THING. I have followed both Baxter and Xoma.......let me tell you in the strongest terms XOMA IS NO BAXTER!!!!! As in XOMA is NO DNA! BASTA YA!!!!! BASTA YA!!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next